Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Jubilant Biosys and Sanofi Deutschland GmbH Enter Into a Strategic Alliance Focusing on Metabolic Disorders Therapeutic Area 2016-01-07 22:48
Merck and Biocartis to Collaborate on New Liquid Biopsy Technology for RAS Biomarker Testing 2016-01-07 16:41
BioAtla And Sinobioway Select First Programs For Strategic Collaboration In China Market 2016-01-06 11:20
Lixte Biotechnology Holdings, Inc. Announces Exclusive Licensing Of Their Lead Anti-Cancer Compound LB-100 For Potential Treatment Of Hepatocellular Carcinoma In Asia To Taipei Medical University 2016-01-05 09:06
Teikoku Pharma USA, Inc. Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula 2015-12-29 03:53
Lima Corporate Continues Their Successful Path With a New Owner 2015-12-23 22:19
More Patients with Lung Cancer Could Benefit from Immunotherapy, Study Shows 2015-12-21 13:40
Afatinib a Better Choice for EGFR-mutated Lung Cancer in First-line Treatment 2015-12-21 10:11
HKSTP and GIBH Co-organise Hong Kong & Guangzhou International Conference on Stem Cell & Regenerative Medicine 2015-12-20 17:58
New-age Technology Capable of Targeted Drug Delivery Thrives 2015-12-16 22:35
AMRI Acquires Whitehouse Laboratories 2015-12-15 22:34
Cathay Industrial Biotech, Ltd Announces $135M in New Financing for Monomer and Bio-Polyamide Expansion 2015-12-14 18:48
APACMed Implements Universal Code of Ethical Conduct for Corporate Members 2015-12-11 08:00
China Cord Blood Corporation Announces Results of 2015 Annual General Meeting 2015-12-10 22:00
Liposome-encapsulated Vincristine Made Available to Acute Lymphoblastic Leukemia Patients Through Global myTomorrows Platform 2015-12-10 21:30
Covalon Announces Expansion into China with New Subsidiary in Shanghai 2015-12-10 21:00
India Country Focus at Pharmaceutical Exhibition in Jakarta 2015-12-10 17:20
APACMed Kicks Off Asia Pacific MedTech Forum 2015 2015-12-10 08:00
Novogen Appoints Dr James Garner as Chief Executive Officer 2015-12-10 06:02
BioAtla Enters Into Strategic License And Option Agreement With Pfizer For A New Class Of Antibody Therapeutics 2015-12-08 10:00
1 527 528 529 530 531